Nothing has changed since punters were happy to pay $2+ for BLT. In fact, with the demise of the competition's RNA-based construct BLT's position is even stronger. BLT's construct is DNA- based and has all the advatages documented on their website.
It's stating the obvious to say that we need positive results from the HepC trial to truly reward us for our patience.
